177 related articles for article (PubMed ID: 2117519)
1. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
[TBL] [Abstract][Full Text] [Related]
2. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
[TBL] [Abstract][Full Text] [Related]
3. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Schwam H; Baldwin JJ; Christy ME; Ponticello GS
J Ocul Pharmacol; 1990; 6(1):9-22. PubMed ID: 2362161
[TBL] [Abstract][Full Text] [Related]
4. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
Wang RF; Serle JB; Podos SM; Surgrue MF
Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
[TBL] [Abstract][Full Text] [Related]
5. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
Sugrue MF
J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343
[TBL] [Abstract][Full Text] [Related]
6. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys.
Wang RF; Serle JB; Podos SM; Sugrue MF
Arch Ophthalmol; 1990 Apr; 108(4):511-3. PubMed ID: 2322152
[TBL] [Abstract][Full Text] [Related]
7. 4-substituted thiophene- and furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
Hartman GD; Halczenko W; Smith RL; Sugŕue MF; Mallorga PJ; Michelson SR; Randall WC; Schwam H; Sondey JM
J Med Chem; 1992 Oct; 35(21):3822-31. PubMed ID: 1433194
[TBL] [Abstract][Full Text] [Related]
8. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
Maren TH; Bar-Ilan A; Conroy CW; Brechue WF
Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
[TBL] [Abstract][Full Text] [Related]
9. Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamides.
Shepard KL; Graham SL; Hudcosky RJ; Michelson SR; Scholz TH; Schwam H; Smith AM; Sondey JM; Strohmaier KM; Smith RL
J Med Chem; 1991 Oct; 34(10):3098-105. PubMed ID: 1920359
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
King TC; Gum GG; Gelatt KN
Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
[TBL] [Abstract][Full Text] [Related]
11. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
[TBL] [Abstract][Full Text] [Related]
12. MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility.
Serle JB; Lustgarten JS; Lippa EA; Camras CB; Panebianco DL; Podos SM
Arch Ophthalmol; 1990 Jun; 108(6):838-41. PubMed ID: 2190547
[TBL] [Abstract][Full Text] [Related]
13. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
14. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
Pfeiffer N; Grehn F; Hennekes R; Garus H
Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent].
Kobayashi M; Naito K
Nihon Yakurigaku Zasshi; 2000 Jun; 115(6):323-8. PubMed ID: 10948564
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies on L-671,152, a topically effective ocular hypotensive carbonic anhydrase inhibitor.
Sugrue MF; Mallorga P; Schwam H; Baldwin JJ; Ponticello GS
Br J Pharmacol; 1989 Dec; 98 Suppl():820P. PubMed ID: 2611526
[No Abstract] [Full Text] [Related]
17. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits.
Sugrue MF; O'Neill-Davis L
J Ocul Pharmacol; 1991; 7(3):201-11. PubMed ID: 1783853
[TBL] [Abstract][Full Text] [Related]
18. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys.
Wang RF; Serle JB; Podos SM; Sugrue MF
Arch Ophthalmol; 1991 Sep; 109(9):1297-9. PubMed ID: 1929960
[TBL] [Abstract][Full Text] [Related]
19. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides.
Prugh JD; Hartman GD; Mallorga PJ; McKeever BM; Michelson SR; Murcko MA; Schwam H; Smith RL; Sondey JM; Springer JP
J Med Chem; 1991 Jun; 34(6):1805-18. PubMed ID: 2061922
[TBL] [Abstract][Full Text] [Related]
20. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
Brechue WF; Maren TH
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
